 Pharmacokinetics low-molecular-weight heparin unfractionated heparin elective aortobifemoral bypass grafting Perioperative monitoring administration heparin empirical basis wide variation patient response elimination rate problem intervention basis perioperative monitoring forms heparin different pharmacokinetic properties unfractionated heparin low-molecular-weight heparin bioavailability subcutaneous administration linear clearance mechanism prolonged half-life effective postoperative vein thrombosis characteristics low-molecular-weight heparin predictable levels heparin activity study pharmacokinetics low-molecular-weight heparin unfractionated heparin intravenous injection patients undergoing aortic graft surgery Heparin activity heparin administration minutes administration anti-Xa activity low-molecular-weight heparin group variation sustained unfractionated heparin group Fibrin degradation products anti-factor Xa levels low-molecular-weight heparin group correlation unfractionated heparin group anti-factor Xa activity low-molecular-weight heparin contrast unfractionated heparin reversible protamine administration blood loss comparable groups contrast pharmacokinetic profiles low-molecular-weight heparin unfractionated heparin similarity intravenous injection patients undergoing aortobifemoral bypass grafting Factors pharmacokinetic behavior heparin